Received May 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | FF8841 | IM / LA |
resident passed away
PARKINSON'S DISEASE WITHOUT DYSKINESIA, WITHOUT MENTION OF FLUCTUATIONS, DEMENTIA IN OTHER DISEASES CLASSIFIED ELSEWHERE, UNSPECIFIED SEVERITY, WITHOUT BEHAVIORAL DISTURBANCE, PSYCHOTIC DISTURBANCE, MOOD DISTURBANCE, AND ANXIETY, LOCALIZATION-RELATED (FOCAL) (PARTIAL) SYMPTOMATIC EPILEPSY AND EPILEPTIC SYNDROMES WITH COMPLEX PARTIAL SEIZURES, NOT INTRACTABLE, WITHOUT STATUS EPILEPTICUS, DISORDER OF THE AUTONOMIC NERVOUS SYSTEM, UNSPECIFIED, HYPERLIPIDEMIA, UNSPECIFIED, LIVER DISEASE, UNSPECIFIED, TYPE 2 DIABETES MELLITUS WITHOUT COMPLICATIONS
Res admitted on 1/16/2024 the following medications were scheduled with admit: Carbidopa- levodopa, Haloperidol, Atorvastatin, Hydroxyzine, Divalproex sodium, Acetaminophen, Polyethylene Powder,
Clonazepam, Diazepam, Lorazepam, Quetiapine